(Q34371142)

1 August 2017

Impact of age on outcomes after bone marrow transplantation for acquired aplastic anemia using HLA-matched sibling donors (English)

1 reference

1 August 2017

1 reference

1 reference

1 reference

acquired aplastic anemia

1 reference

6

Robert Peter Gale

1 reference

1 August 2017

Jakob R Passweg

9

1 reference

ORCID Public Data File 2021

Ruta Brazauskas

3

object named as

Ruta Brazauskas

1 reference

1 August 2017

Vikas Gupta

1

1 reference

1 August 2017

Mary Eapen

2

1 reference

1 August 2017

Jeanette Carreras

4

1 reference

1 August 2017

Mahmoud Aljurf

5

1 reference

1 August 2017

Gregory A Hale

7

1 reference

1 August 2017

Osman Ilhan

8

1 reference

1 August 2017

Ollé Ringdén

10

1 reference

1 August 2017

Mitchell Sabloff

11

1 reference

1 August 2017

Hubert Schrezenmeier

12

1 reference

1 August 2017

Gerard Socié

13

1 reference

1 August 2017

Judith C W Marsh

14

1 reference

1 August 2017

language of work or name

1 reference

17 September 2010

1 reference

1 August 2017

1 reference

1 August 2017

95

1 reference

1 August 2017

12

1 reference

1 August 2017

2119-2125

1 reference

Improved outcome of patients older than 30 years receiving HLA-identical sibling hematopoietic stem cell transplantation for severe acquired aplastic anemia using fludarabine-based conditioning: a comparison with conventional conditioning regimen

1 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2995571

Guidelines for the diagnosis and management of aplastic anaemia

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2995571

Predicting response to immunosuppressive therapy and survival in severe aplastic anaemia

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2995571

Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT).

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2995571

Current concepts in the pathophysiology and treatment of aplastic anemia

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2995571

Allogeneic stem cell transplantation for severe acquired aplastic anaemia using a fludarabine-based preparative regimen

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2995571

Treatment of acquired severe aplastic anemia: bone marrow transplantation compared with immunosuppressive therapy--The European Group for Blood and Marrow Transplantation experience

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2995571

Pathophysiology and treatment of graft-versus-host disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2995571

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2995571

1994 Consensus Conference on Acute GVHD Grading

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2995571

Marrow transplants from matched unrelated donors for aplastic anaemia using alemtuzumab, fludarabine and cyclophosphamide based conditioning

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2995571

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2995571

Addition of low-dose busulfan to cyclophosphamide in aplastic anemia patients prior to allogeneic bone marrow transplantation to reduce rejection

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2995571

Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2995571

Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2995571

Primary treatment of acquired aplastic anemia: outcomes with bone marrow transplantation and immunosuppressive therapy. Seattle Bone Marrow Transplant Team.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2995571

Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party

27 October 2018

1 reference

12 December 2020

Long-term outcome after bone marrow transplantation for severe aplastic anemia

1 reference

12 December 2020

Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry

1 reference

12 December 2020

Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia

1 reference

12 December 2020

Fludarabine and cyclophosphamide based reduced intensity conditioning (RIC) regimens reduce rejection and improve outcome in Indian patients undergoing allogeneic stem cell transplantation for severe aplastic anemia

1 reference

12 December 2020

Graft-versus-host disease following marrow transplantation for aplastic anemia: different impact of two GVHD prevention strategies

1 reference

12 December 2020

Treatment strategies for patients with severe aplastic anemia

1 reference

12 December 2020

Current results of bone marrow transplantation in patients with acquired severe aplastic anemia. Report of the European Group for Blood and Marrow transplantation. On behalf of the Working Party on Severe Aplastic Anemia of the European Group for Bl

1 reference

12 December 2020

10.3324/HAEMATOL.2010.026682

Identifiers

DOI

1 reference

1 August 2017

1 reference

1 August 2017

1 reference